Get Quote
 
 
Gainers Losers Latest NAV Scheme Profile  
 
Search Scheme 

SCHEME SNAPSHOT

Invesco India PSU Equity Fund - Direct Plan
Fund : Invesco Mutual Fund
Category : Equity - Diversified
Type : Open Ended
NAV(23/06/2017) 19.3900
Percentage Returns :
1 Month Ago : -1.07%
3 Months Ago : 2.92%
1 Year Ago : 34.28%
Snapshot
Inception Date 1/1/2013 Fund Manager Mr. Pranav Gokhale
Initial Price 10.00 Min. Invest. Rs.5000
Objectives To generate capital appreciation by investing in Equity and Equity Related Instruments of companies where the Central / State Government(s) has majority shareholding or management control or has powers to appoint majority of directors.
Entry Load nil
Exit Load 1% - if redeemed/switched-out on or before 1 year from the date of allotment. Nil - if redeemed/switched-out after 1 year from the date of allotment.
Trailing Returns
  1 Mth 3 Mths 1 Yr 3 Yrs
Scheme-1.072.9234.2816.54
Category2.546.8622.3639.47
Sensex2.556.1615.327.55
Nifty2.015.3815.778.51
NAV Chart
Other Options  Asset Allocation
OptionsNAV
Dividend15.7100 (23/06/2017)
Growth19.3900 (23/06/2017)
Holding DateValue (Rs. Cr)
30/04/2017110.17
28/02/201798.99
30/11/201687.12
31/10/201686.43
30/09/201684.33
Mutual Fund Registrar
3rd Floor, GYS Infinity Paranjpe B Scheme Subhash Road Vile Parle (East), Mumbai, Maharashtra, India - 400057
Email : mfservices@invesco.com
Web : http://www.invescomutualfund.com
Karvy Computershare Pvt. Ltd.
 

Sector Watch

 
  Company
Name
NSE
Current
NSE
Change (%)
NSE
Volume
BSE
Current
BSE
Change (%)
BSE
Volume
849.75 0.93 591,602
847.60 0.68 18,544
257.30 -1.15 3,234,463
257.40 -1.21 183,433
93.40 -0.32 6,118,660
93.20 -0.53 663,663
2,845.70 1.00 223,966
2,840.45 0.69 15,569
1,154.75 -1.14 312,362
1,154.30 -1.17 30,973
24,286.40 0.25 11,720
24,277.00 -0.09 797

TOP MF News

Mutual fund managers continued to be bullish on bank shares, with their allocation to the sector reaching an all time-high of over...

Company News

Drug firm Wockhardt today said it has settled an ongoing lawsuit over supply contract for a product with Teva Pharmaceuticals. The...